Fig. 3From: The effects of oxaliplatin-based adjuvant chemotherapy in high-risk stage II colon cancer with mismatch repair-deficient: a retrospective studyKaplan–Meier plots showing outcome in patients with stage II dMMR colon cancers according to treatment and high-risk status. a Disease-free survival (DFS) in all patients. b DFS in highrisk group. c DFS in lowrisk groupBack to article page